Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.8K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.8K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

65
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
65
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

389
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
389
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

104
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
104
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

58
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
58
Drug Delivery: Overview01:16

Drug Delivery: Overview

1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology.

Acta Cardiologica Sinica·2026
Same author

Targeted lipidomics approach reveals the role of ceramide signalling in the pathophysiology of Neuromyelitis optica spectrum disorders.

Multiple sclerosis and related disorders·2026
Same author

PCOS combined with obesity aggravates the metabolic and immune abnormality in females.

BMC women's health·2026
Same author

A Comprehensive Workflow for Plasma Proteomics by Mass Spectrometry: A Strategy for Biomarker Discovery in Systemic Human Diseases.

Journal of visualized experiments : JoVE·2026
Same author

Regio- and Diastereoselective Aminopyridylation of Bicyclo[1.1.0]butanes with <i>N</i>‑Aminopyridinium Ylides Enabled by Photoredox Catalysis.

Precision chemistry·2026
Same author

Modulation of COX-2, 5-LOX, and cytokine signalling by <i>Carica papaya</i> L. Leaf cultivar 'Red Lady' flavonoids in inflammation: <i>in-vitro</i> and <i>in-silico</i> insights.

Natural product research·2025

Related Experiment Video

Updated: Mar 6, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.7K

Development Considerations for Nanocrystal Drug Products.

Mei-Ling Chen1, Mathew John1, Sau L Lee1

  • 1Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA.

The AAPS Journal
|March 11, 2017
PubMed
Summary

Nanocrystal technology enhances drug delivery for poorly soluble active pharmaceutical ingredients (APIs). A review of FDA submissions highlights key development considerations and challenges for these advanced drug formulations.

Keywords:
absorptionbiopharmaceuticsnanocrystalnanotechnologyquality

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

10.2K

Related Experiment Videos

Last Updated: Mar 6, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.7K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

10.2K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Nanotechnology

Background:

  • Nanocrystal technology improves bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs).
  • Over 80 drug products containing nanocrystals have been submitted to the US Food and Drug Administration (FDA).
  • These products are utilized across various therapeutic areas and administration routes.

Purpose of the Study:

  • To conduct a retrospective analysis of FDA submissions for nanocrystal drug products.
  • To identify critical developmental considerations and challenges associated with nanocrystal formulations.
  • To understand the landscape of nanocrystal drug development based on regulatory submissions.

Main Methods:

  • Retrospective analysis of US FDA drug product applications containing nanocrystals.
  • Categorization of drug products based on route of administration and Biopharmaceutics Classification System (BCS).
  • Evaluation of reported development emphasis, including manufacturing controls, impurity management, and stability.

Main Results:

  • Over 60% of submissions were for oral administration, primarily involving BCS Class II drugs (low solubility, high permeability).
  • Food effect on bioavailability was reduced for most nanocrystal formulations compared to micronized versions.
  • Development focused on in-process controls, impurity mitigation, and stability, revealing challenges in particle size determination, polymorphism identification, and specification setting.

Conclusions:

  • Nanocrystal technology is a significant advancement for improving drug delivery and bioavailability.
  • Key development challenges include precise characterization and robust specification setting for nanocrystal products.
  • Regulatory review highlights the importance of manufacturing controls and stability for successful nanocrystal drug development.